Table 2.
The effect of treatment with different concentrations of Amygdalus lycioides extract on serum fasting blood glucose (FBS) and oral glucose tolerance test (OGTT) in streptozocin-induced diabetic rats
| Groups |
Initial FBS
(mg/dL) |
FBS 4 days after streptozocin (mg/dL) | FBS 11 days after streptozocin (mg/dL) | FBS 18 days after streptozocin (mg/dL) |
OGTT
(mg/dL) |
|---|---|---|---|---|---|
| Solvent | 76.16 ± 3.80 | 497.33 ± 28.90 | 367 ± 58.82 | 454 ± 6.44 | 633.5 ± 4.78 |
|
Amygdalus lycioides
(125 mg/kg) |
77 ± 3.06 | 495.66 ± 29.53 | 387.5 ± 9.25 | 423 ± 13.69 | 579 ± 16.35 |
|
Amygdalus lycioides
(250 mg/kg) |
80.33 ± 3.01 | 461.33 ± 33.96 | 339 ± 35.19 | 353 ± 65.93 | 538.66 ± 51.84 |
|
Amygdalus lycioides
(500 mg/kg) |
75.83 ± 3.62 | 506.66 ± 26.29 | 320.66 ± 47.49 | 362 ± 60.03 | 537.83 ± 41.4 |
|
Amygdalus lycioides
(1000 mg/kg) |
82.5 ± 5.03 | 437.33 ± 22.11 | 244 ± 35.28 | 147 ± 38.59*** | 375.83 ± 77.67** |
| Insulin NPH (3 IU) | 75.66 ± 2.55 | 505.66 ± 36.80 | 93.5 ± 20.05*** | 207.16 ± 75.23** | 329.83 ± 73.19** |
Data are expressed as mean ± SEM of data in each group.
**
P < 0.01 and
***
P < 0.001, compared with corresponding solvent-treated diabetic group.